CONMED Corporation CNMD
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 14.61% | -48.73% | -53.81% | -64.47% | -51.37% |
| Total Depreciation and Amortization | 3.72% | 3.83% | 4.24% | 3.72% | 2.69% |
| Total Amortization of Deferred Charges | -18.30% | -10.86% | -6.40% | -3.58% | -6.77% |
| Total Other Non-Cash Items | 2.28% | 174.73% | 324.86% | 1,777.62% | 329.36% |
| Change in Net Operating Assets | -171.64% | 23.54% | -32.39% | 71.17% | -90.06% |
| Cash from Operations | -12.75% | -8.85% | -20.49% | 2.23% | -6.85% |
| Capital Expenditure | 27.30% | 4.97% | -27.59% | -51.38% | -34.79% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -335.29% | -335.29% | -335.29% | -- | -- |
| Cash from Investing | 137.42% | 120.95% | 0.42% | -60.17% | -28.68% |
| Total Debt Issued | 104.78% | 112.08% | 10.81% | -4.04% | -12.46% |
| Total Debt Repaid | -85.06% | -93.00% | -0.53% | 3.37% | 9.66% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 74.97% | 49.89% | 24.77% | -0.39% | -0.44% |
| Other Financing Activities | -59.93% | -56.47% | -12.17% | 32.87% | 41.11% |
| Cash from Financing | 4.28% | -3.35% | 19.96% | 10.05% | 5.78% |
| Foreign Exchange rate Adjustments | -584.57% | -211.13% | 158.46% | 189.86% | -67.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,857.36% | -33.02% | -127.91% | 9,935.58% | -94.20% |